Roles for miRNAs in endocrine resistance in breast cancer

Keyphrases

• Breast Cancer 100%
• MicroRNA 100%
• Endocrine Resistance 100%
• Estrogen Receptor-α (ER-α) 66%
• Tumor 33%
• Gene Targeting 33%
• Breast Cancer Patients 33%
• Fulvestrant 33%
• Acquired Resistance 33%
• Letrozole 33%
• Metastatic Disease 33%
• Aromatase Inhibitors 33%
• Estrogen Therapy 33%
• Endocrine Therapy 33%
• Bona Fide 33%
• ICI 182,780 33%
• Disruptor 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Breast Cancer 100%
• microRNA 100%
• Estrogen Receptor Alpha 66%
• Letrozole 33%
• Endocrine Therapy 33%
• Tamoxifen 33%
• Biological Marker 33%
• Fulvestrant 33%
• Aromatase Inhibitor 33%
• Antiestrogen 33%
• Neoplasm 33%